Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc. > Acreage beat the expectations easily as well.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(474)
•••
Comment by DSEEGSon Aug 12, 2020 2:44pm
125 Views
Post# 31399460

RE:RE:RE:RE:RE:Acreage beat the expectations easily as well.

RE:RE:RE:RE:RE:Acreage beat the expectations easily as well.
ilvmyt5s wrote: lol like the Nuverra deal?????


ilvmyt5s wrote:
DSEEGS wrote:
ilvmyt5s wrote: Does anyone know why WEED would buy a money losing company for their US expansion? Why not purchase a profitable company that pays a dividend?




Daredevil1964 wrote:
EPS of $-0.11 beats by $0.07
 
Revenue of $43.77M (19.47% Y/Y) beats by $9.51M

 


The sheer amount of licenses they hold. Extremely Valuable and difficult process to acquire . 

 






Nuuvera had no experience producing cannabis and has posted virtually no revenue.
It was incorporated just in January2017, and went public this January through a reverse takeover of a shell company, a mere three weeks before the offer from Aphria.

 Not sure why you compare with NuUvera care to explain? Nuuvera had no U.S exposure which is pretty much the T.A.M.....


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities